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Macrophages exert potent effector functions against
invading microorganisms but constitute, paradoxi-
cally, a preferential niche for many bacterial strains
to replicate. Using amodel of infection by Salmonella
Typhimurium, we have identified a molecular mech-
anism regulated by the nuclear receptor LXR that
limits infection of host macrophages through
transcriptional activation of the multifunctional
enzyme CD38. LXR agonists reduced the intracel-
lular levels of NAD+ in a CD38-dependent manner,
counteracting pathogen-induced changes in macro-
phage morphology and the distribution of the F-actin
cytoskeleton and reducing the capability of non-
opsonized Salmonella to infect macrophages.
Remarkably, pharmacological treatment with an
LXR agonist ameliorated clinical signs associated
with Salmonella infection in vivo, and these effects
were dependent on CD38 expression in bone-
marrow-derived cells. Altogether, this work reveals
an unappreciated role for CD38 in bacterial-hostCell Rep
This is an open access article under the CC BY-Ncell interaction that can be pharmacologically ex-
ploited by activation of the LXR pathway.INTRODUCTION
Macrophages are essential mediators of the innate immune
response. Through phagocytosis, macrophages internalize mi-
crobial pathogens, which are subsequently killed and digested
in intracellular phagolysosomes (Haas, 2007). Several patho-
genic microorganisms have, however, developed strategies to
actively invade host cells and evade microbial digestion within
the host endosomal system. In fact, despite their repertoire of
microbicidal tools, macrophages represent niches in which
many pathogens have established themselves for intracellular
replication and dissemination (Price and Vance, 2014). For
example, Salmonella enterica serovar Typhimurium (S. Typhimu-
rium) fosters its own uptake by non-phagocytic epithelial cells
and phagocytic cells, and infection and intracellular survival in
macrophages is required for full virulence and dissemination
(Haraga et al., 2008). Invasive Salmonellae strains can enter
macrophages by several endocytic processes, including macro-
pinocytosis induced by factors secreted by the type III secretion
system (T3SS). Within infected host cells, the bacterium firstorts 18, 1241–1255, January 31, 2017 ª 2017 The Author(s). 1241
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
uses a second T3SS to transform the phagosome into a Salmo-
nella-containing vacuole that supports bacterial replication and
then induces macrophage pyroptosis for dissemination (Guiney
and Lesnick, 2005).
Nuclear receptors are a family of ligand-activated transcription
factors with diverse functions in physiology. Liver X receptors
(LXRs) are nuclear receptors that can be pharmacologically acti-
vated by high-affinity agonists to subsequently regulate the
expression of genes involved in lipid homeostasis. Two LXR iso-
forms have been identified, namely LXRa and LXRb, both of
which heterodimerize with retinoid X receptors (RXRs) to posi-
tively modulate target gene expression (Hong and Tontonoz,
2014). Apart from their metabolic functions, LXRs play important
roles in the regulation of immune responses. Through different
mechanisms, LXRs repress a subset of pro-inflammatory genes
induced by pattern recognition receptor engagement (Ghisletti
et al., 2007; Ito et al., 2015) or by interferon gamma (IFN-g) (Pasc-
ual-Garcı´a et al., 2013; Lee et al., 2009). On the other hand, the
LXR pathway is involved in the acquisition of a macrophage de-
activated phenotype (A-Gonzalez et al., 2009).
Based on the anti-inflammatory actions of LXR agonists, initial
predictions anticipated that LXR activation could negatively
impact the capability of immune cells to establish an aggressive
response against pathogens. However, increased susceptibility
to infection by Mycobacterium tuberculosis or Listeria monocy-
togenes has been observed in LXR-deficient mice (Joseph
et al., 2004; Korf et al., 2009), and LXR activation prevented
macrophage apoptosis induced by virulent bacteria, including
Bacillus anthracis and S. Typhimurium (Valledor et al., 2004),
which suggests that the LXR pathway exerts complex regulatory
actions that affect microbe-host cell interaction. In this work, we
have further investigated the involvement of LXR activity in im-
mune cell function during infection by S. Typhimurium. Interest-
ingly, the results reported here identify a molecular mechanism
regulated by LXRs that serves to limit infection of host macro-
phages through modulation of cellular NAD metabolism.
RESULTS
LXR Activity Limits Macrophage Infection by
S. Typhimurium
To investigate the role of the LXR pathway in host-path-
ogen interaction, we treated primary bone-marrow-derived
macrophages with synthetic high-affinity LXR agonists (either
TO901317 (T1317) or GW3965) and then infected the cells
with S. Typhimurium strain SV5015 harboring the plasmid
pBR.RFP.1, which encodes red fluorescent protein. Confocal
fluorescence microscopy studies indicated that LXR agonists
reduce the amount of intracellular bacteria and the percentage
of infected macrophages after 30 min of infection (Figures 1A,
S1, and S2A). Reduced bacteria burden was corroborated with
flow cytometry studies (Figures 1B and S2B) and by determina-
tion of viable bacterial colony-forming units (CFUs) after macro-
phage cell lysis (Figure 1C). The agonists did not inhibit infection
of cells deficient in LXRa and LXRb (LXR/) (Figures 1A, 1B, and
S2B), indicating that the effects of these compounds were LXR
dependent and LXR specific. Interestingly, the rate of intracel-
lular bacterial replication during the first 5 hr post-infection was1242 Cell Reports 18, 1241–1255, January 31, 2017not altered upon LXR activation, as the differences between
agonist- and vehicle-treated cells over a time-course of 5 hr
were equivalent to the differences observed at 30min of infection
(Figure 1D). These results suggested that LXR activation inter-
feres with early events during bacterial cell interaction with
host macrophages. On the other hand, a time-course assay re-
vealed that prolonged treatment with the LXR agonist is required
for effective inhibition of macrophage infection (Figure 1E).
Pharmacological treatment with T1317 in vivo also reduced
intracellular macrophage infection by S. Typhimurium in an intra-
peritoneal model of infection (Figure 1F). Importantly, the effects
of T1317 were not indirectly mediated by any substantial
decrease in the ratio of residentmacrophages versus neutrophils
before the infection (Figure S2C). Interestingly, the LXR agonist
did not influence phagocytosis of immunoglobulin G (IgG)-
opsonized Salmonella cells (Figure 1G), suggesting that LXR
activation induces a mechanism that protects macrophages
from infection by this microorganism in the absence of opsoniz-
ing antibodies.
We next determined whether LXR activation affects the inter-
nalization of other bacterial pathogens. These studies revealed
that LXR activity inhibits macrophage infection by an enteroinva-
sive strain of Escherichia coli (EIEC 0124:H30) without affecting
phagocytosis of non-invasive E. coli (Figure S2D) or internaliza-
tion of Fluoresbright yellow green microspheres (Figure S2E),
thus suggesting that LXR activity selectively affects invasive
mechanisms induced by pathogenic bacteria.
Morphological studies using fluorescent phalloidin to stain fila-
mentous actin (F-actin) showed that macrophages incubated
with S. Typhimurium acquire a round pancake-like shape within
minutes after bacterial exposure (Figure 1H), a morphological
feature previously associated to inflammatory macrophage po-
larization (McWhorter et al., 2013). Remarkably, pretreatment
with an LXR agonist strongly inhibited the changes in macro-
phage morphology induced upon S. Typhimurium infection
without altering the morphology of resting cells (Figure 1H, see
quantification in Figure 2E). Moreover, LXR activation also
reduced the expression of several pro-inflammatory mediators
in infected macrophages (Figure S2F).
Interestingly, expression profiling experiments revealed that
interference with bacterial internalization was not mediated by
repressionofmembrane receptors traditionally involved in recog-
nition and/or phagocytosis of bacterial products (Figure S3).
A recent study demonstrated a role for cytosolic nicotinamide
adenine dinucleotide (NAD+) in the control of the organization of
the actin cytoskeleton required for the spreading performance
and the formation of actin-rich membrane protrusions in acti-
vated macrophages (Venter et al., 2014). Based on these obser-
vations, we evaluated whether altering NAD+ levels affects the
capability of LXRs to interfere with macrophage morphology
and/or internalization of S. Typhimurium. In mammalian cells,
nicotinamide phosphoribosyltransferase (NAMPT) is the rate-
limiting enzyme in the biosynthesis of NAD+ through the salvage
pathway. Incubation with FK866, a specific NAMPT inhibitor, re-
sulted in partial inhibition of the capability of macrophages to
internalize S. Typhimurium (Figure 2A). Interestingly, activation
of the LXR pathway significantly reduced the intracellular
levels of NAD+ (Figure 2B), and addition of exogenous NAD+
Figure 1. LXR Activation Limits Macro-
phage Infection by Non-opsonized S. Typhi-
murium
(A) Macrophages fromWT (n = 5) or LXR/ (n = 4)
mice treated with the LXR agonist T1317 (1 mM,
24 hr) or DMSO and infected with S. Typhimurium
(30 min). Analysis of the percentage of infected
macrophages (top) and the amount of intracellular
bacteria (bottom) by confocal fluorescence mi-
croscopy. Data represent mean ± SEM (two-way
ANOVA Bonferroni). The dataset in WT cells in-
cludes data from Figure 2C.
(B) Analysis of macrophage infection by flow cy-
tometry after incubation with the LXR agonists
T1317 or GW3965 (1 mM, 24 hr). Macrophages
were infected with S. Typhimurium for 30 min at
37C. As a control, bacterial cell attachment to
macrophages (without internalization) was also
assessed by carrying out the infection at 4C.
Each experiment was performed in triplicate.
Shown is a representative experiment from each
genotype (mean ± SD) from n = 5 (WT) or n = 4
(LXR/) independent experiments (ANOVA Bon-
ferroni).
(C) Quantification of intracellular S. Typhimurium
burden. The cells were infected for 30 min. Serial
dilutions of cell lysates were plated on agar and
allowed to grow at 37C. Bacterial CFUs were
counted 24 hr later. Data represent mean ± SEM
from n = 3 independent experiments (each
including biological duplicates or triplicates)
(paired t test).
(D) Confocal fluorescence microscopy evaluating
the effects of T1317 on intracellular bacterial
burden over time. Data represent mean ± SEM;
n = 5 (30 min), n = 7 (90 min), or n = 9 (300 min)
(paired t test for each time post-infection).
(E) Macrophages were treated with T1317 for the
indicated periods of time, and the inhibitory effects
on macrophage infection were evaluated by flow
cytometry. Data are expressed as percent reduc-
tion in the number of infected cells (versus infec-
tion in the absence of T1317) (mean ± SD; n = 5;
Kruskal-Wallis Dunn. Similar results were obtained
in an independent experiment performed in tripli-
cates.
(F) In vivo infected cells analyzed by confocal mi-
croscopy. C57BL/6malemicewere first subjected
to an i.p. injection of T1317 (10mg/kg animal; 24 hr) or vehicle (DMSO in PBS; 24 hr) and then infected i.p. with S. Typhimurium (107 CFU per animal; 30min); n = 5
animals/group. Mean bars are indicated (t test).
(G) Bacterial uptake in the presence or absence of opsonizing anti-Salmonella LPS IgG. Data represent mean ± SEM (n = 3; Kruskal-Wallis Dunn).
(H) Representative images of infected macrophages stained with phalloidin (F-actin, purple) and DAPI (nuclei, blue) (n = 4). Scale bars, 10 mm.
See also Figures S1 and S2. *p < 0.05, **p < 0.01.counteracted the ability of the LXR agonist to reduce macro-
phage infection (Figure 2C), with no effect on the levels of infec-
tion in control macrophages (not exposed to LXR agonists).
Theseeffects correlatedwith theobservation that in thepresence
of exogenous NAD+, activation of the LXR pathway did not inhibit
morphological changesassociatedwith host cell-pathogen inter-
action (Figures2Dand2E). In activatedmacrophages, changes in
macrophage morphology are accompanied by an increase in
F-actin-rich dorsal membrane ruffling, with curved or circular
protrusions directed upright that precede macropinocytosis
(Luo et al., 2014). Interestingly, the LXR agonist interfered withdorsal F-actin accumulation in Salmonella-infected cells, and
addition of exogenous NAD+ counteracted these effects. Alto-
gether, these observations prompted us to consider whether
LXR activation modulates the expression of factors that
contribute to NAD+ metabolism as a mechanism protecting
macrophages from excessive bacterial internalization.
LXR Agonists Induce the Expression of the NAD
Glycohydrolase CD38
In general, NAD+ and its phosphorylated and reduced forms
participate as coenzymes in oxidation-reduction reactionsCell Reports 18, 1241–1255, January 31, 2017 1243
Figure 2. NAD+ Addition Suppresses the Ef-
fects of LXR Activation on Macrophage
Infection
(A) Confocal fluorescence microscopy analysis of
the amount of infected macrophages after treat-
ment with the NAMPT inhibitor FK866 (10 nM) or
vehicle for 24 hr. Data represent mean ± SEM
(n = 4; paired t test).
(B) Analysis of intracellular NAD+ levels with a NAD
cycling assay. The cells were pre-treated with
agonists for the LXR-RXR heterodimer, T1317 and
LG268 (1 mM each), or vehicle (DMSO) for 24 hr.
Data represent mean ± SEM (n = 6; paired t test).
(C) Effects of exogenous addition of NAD+ on
macrophage infection. The cells were pretreated
with T1317 (1 mM, 24 hr) or DMSO and then incu-
batedwith NAD (1mM) for 2 hr before the infection.
Results of confocal microscopy studies are shown.
Data represent mean ± SEM (n = 4; two-way
ANOVABonferroni). Thedata fromWTcells arealso
included as part of the WT dataset in Figure 1A.
(D) Effects of NAD+ on S. Typhimurium-induced
changes in macrophage morphology; scale bars,
10 mm. Representative images; n = 4.
(E and F) Cell elongation ratio (E) and dorsal
F-actin accumulation index (F). Data represent
mean ± SEM (n = 4; ANOVA Bonferroni).
*p < 0.05, **p < 0.01.without net consumption of intracellular NAD. In contrast, NAD+
is consumed as a substrate by enzymatic activities that mediate
protein lysine deacylation and ADP-ribose transfer or synthesis
(Belenky et al., 2007). To assess if LXR activation modulates the
expression of enzymes that participate in NAD+ biosynthesis or
consumption, we analyzed expression-profiling data obtained
from macrophages stimulated with an LXR agonist (Figure 3A).
The expression of most of the genes evaluated, including
Nampt, was not altered upon LXR activation. However, selec-
tive induction of Cd38 was observed in cells treated with the
LXR agonist. CD38 is a type II transmembrane glycoprotein
that catalyzes the conversion of NAD+ into nicotinamide, aden-
osine diphosphate-ribose (ADPR), and cyclic ADPR (cADPR)
(Chini, 2009) and is thus a major regulator of cellular levels of
NAD+ (Aksoy et al., 2006). Induction of CD38 upon LXR activa-
tion was confirmed by qPCR (Figures 3B and 3C) and western
blotting (Figure 3D). It is noteworthy that the basal levels of
Cd38 expression were not significantly reduced in LXR-defi-
cient cells, as it is the case for previously identified LXR target
genes (e.g., Abca1, Abcg1, and Srebp1c; Wagner et al.,
2003); however, Cd38 induction by the LXR agonist was LXR
dependent and LXR specific (Figure 3B). Cd38 expression
was also upregulated in response to a synthetic agonist for1244 Cell Reports 18, 1241–1255, January 31, 2017RXR, LG268 (Figure 3B), and combined
treatment with agonists for LXR and
RXR synergistically upregulated CD38
mRNA and protein expression (Figures
3B, 3E, and 3F) in an LXR-dependent
manner, with both LXRa and LXRb
contributing to Cd38 induction (Fig-
ure 3F). Moreover, these effects trans-lated into increased CD38 protein levels at the cell surface (Fig-
ure 3G) and augmented cellular NADase activity (Figures 3H–
3J). The changes in NADase activity were completely abolished
in either LXR/ or CD38/ macrophages (Figures 3I and 3J),
which correlated with the fact that LXR/RXR agonists signifi-
cantly downregulate intracellular NAD+ levels in wild-type (WT)
cells (Figure 2B), but not in CD38-deficient cells (Figure 3K).
Taken together, these results indicate that CD38 mediates the
increase in NADase activity and the reduction in intracellular
NAD levels upon pharmacological activation of the LXR
pathway.
A putative LXR response element (LXRE) was identified in an
enhancer 2 kb upstream of the transcription initiation site,
which is fully conserved at least in mouse and rat. A fragment
containing the potential LXRE, hereafter named Cd38 enhancer
(Cd38enh), was cloned in a pGL3-promoter vector (pGL3-
Cd38enh), and its activity was characterized in COS-7 cells. Co-
transfection of LXRa and RXRa resulted in maximal induction of
promoter activity in response to a combination of LXR and RXR
agonists (Figure S4). Significant loss of activity was observed af-
ter mutation of the potential LXRE in the Cd38enh region, which
suggests that the site identified here represents a bona fide
LXRE (Figure 3L).
Figure 3. LXR Activation Induces the
Expression of the Multifunctional Enzyme
CD38
(A) Expression profiling frommacrophages treated
with GW3965 (2 mM) or DMSO for 18 hr. Heatmap
representing average fold expression values
(log2 scale) of genes involved in net NAD+ syn-
thesis or consumption in GW3965-treated cells
over DMSO-treated cells (n = 2).
(B and C) qPCR analysis of Cd38 expression in
WT and LXR-deficient macrophages stimulated
with LXR agonists T1317 or GW3965 and/or the
RXR agonist LG268 (1 mM each). Data represent
mean ± SEM (n = 4 with two-way ANOVA Bon-
ferroni in B; n = 3 with t test [with Welch’s
correction] in C). In (B), *p < 0.05, **p < 0.01 vs
control cells from the same genotype; #p < 0.05,
##p < 0.01 vs the same treatment in WT cells.
(D and E) Western blot analysis of CD38 protein
expression in WT (D and E) and LXR-deficient and
CD38-deficient macrophages (E).
(F) qPCR analysis in macrophages WT or deficient
in LXRa (LXRa/), LXRb (LXRb/), or both iso-
forms (LXR/). Data represent mean ± SEM
(n = 4; t test for each genotype).
(G) Flow cytometry analysis of the surface
expression of CD38. Data represent mean ± SEM
(n = 6; t test).
(H–J) Fluorimetric determination of intracellular
NADase activity in WT (H–J), LXR-deficient (I), and
CD38-deficient macrophages (J). Data represent
mean ± SEM (n = 4 in H, n = 3 in I, and n = 5 in J;
Mann-WhitneyUWilcoxon test for eachgenotype).
(K) Intracellular NAD+ levels in CD38-deficient
macrophages. Data represent mean ± SEM (n = 6;
paired t test).
(L) Luciferase reporter studies in COS7 cells co-
transfected with a WT Cd38 enhancer-luciferase
construct (pGL-Cd38enh WT) or a construct
containing a mutated LXRE (pGL-Cd38enh MUT),
as well as plasmids overexpressing LXRa and
RXRa or an empty vector. Transfected cells were
stimulated for 18 hr with either vehicle (DMSO) or
LXR-RXR agonists. Data represent mean ± SEM
(n = 3, left; n = 6, middle; and n = 4, right; ANOVA
Bonferroni comparing transfections with LXR/RXR
coexpression).
See also Figure S4. *p < 0.05, **p < 0.01.Cooperative Effects of LXRs and Inflammatory Signals
on CD38 Expression and NADase Activity
Interestingly, infection by S. Typhimurium strongly induced
macrophage expression of Cd38 (Figure 4A). In agreement with
previous observations (Musso et al., 2001; Iqbal and Zaidi, 2006;
Lee et al., 2012), increased expression of Cd38 was observed
upon prolonged stimulation with IFN-g, lipopolysaccharide
(LPS), or tumor necrosis factor alpha (TNF-a) (Figures 4B and
S5A–S5C). In contrast, Cd38 was not upregulated in macro-
phages alternatively activated by interleukin 4 (IL-4), IL-10, or
transforming growth factor beta (TGF-b) (Figure 4C), despite the
fact that these cytokines did induce specific target genes in
macrophages (Figures S5D–S5F). In line with increased Cd38
expression in classically activated macrophages, inflammatory
mediators reduced intracellular NAD+ levels in aCD38-dependentmanner (Figure 4D). However, despite the ability of CD38 to alter
intracellular NAD+ levels, early ROS production in response to
inflammatory signaling was CD38 independent (Figure 4E).
These studies also led to the unexpected observation that func-
tional LXR expression was required for full induction of Cd38 by
inflammatory signals and that combined activation of inflamma-
tory signaling and the LXR pathway cooperated synergistically
to upregulate Cd38 expression (Figures 4A, 4B, and S5A–S5C)
and NADase activity (Figures 4F and S5G). Sequence analysis
of theCd38enh regioncontaining theLXRE revealed thepresence
of two nuclear factor kB (NF-kB) binding sites, an interferon-
stimulated response element (ISRE), and an AP-1 site in the prox-
imity of the LXRE. Raw264.7 macrophages that stably express
human LXRawere cotransfected with theCd38enh-luciferase re-
porter and a plasmid overexpressing RXRa. In these studies,Cell Reports 18, 1241–1255, January 31, 2017 1245
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cooperation of the LXR pathway with LPS signaling occurred at
the transcriptional level, and these effects were abolished when
the cells were transfected with the mutant LXRE (Figure 4G).
CD38 Mediates the Protective Effects of LXR Agonists
on Macrophage Infection
We next compared the capability of an LXR agonist to protect
WT andCD38-deficientmacrophages from infection byS. Typhi-
murium. Importantly, the lack of functional expression of CD38
inhibited the capability of the LXR agonist to reduce the amount
of infected macrophages and intracellular bacteria (Figure 5A),
effects that were similar to those obtained upon addition of exog-
enous NAD+ in WT cells (Figure 2C). Moreover, activation of
macrophages by IFN-g has been shown to regulate negatively
their capability to internalize non-opsonized bacteria in certain
models of infection (Wang et al., 2014; Sun and Metzger,
2008). Interestingly, in our studies, prolonged stimulation with
IFN-g resulted in decreased infection by non-opsonized Salmo-
nella cells in a CD38-dependent manner (Figure 5B). Taken
together, these results suggest that induction of macrophage
CD38 expression represents a strategy to limit infection of mac-
rophages by live Salmonella cells.
We also determined the inflammatory response to infection in
CD38-deficient macrophages (Figure 5C). To our surprise, the
levels of induction of several cytokines were significantly lower
in CD38-deficient cells as compared to WT cells. However, for
most of the genes examined, LXR agonists were able to repress
inflammatory gene expression in cells lacking functional CD38.
These data suggest that CD38 selectively facilitates protection
against invasive bacterial cell entry but does not contribute
broadly to the LXR-mediated anti-inflammatory response in vitro.
Intrinsic to its NADase activity, CD38mediates the synthesis of
ADPR, cADPR, and nicotinic acid adenine dinucleotide phos-
phate (NAADP), which are Ca2+ mobilizing compounds (Musso
et al., 2001). Video microscopic measurements from fura-
2-AM-loaded cells showed higher basal levels of cytosolic
Ca2+ in WT macrophages than in LXR-deficient cells (Figure 5D,
top). However, Ca2+ storage in the endoplasmic reticulum (ER)
was not depleted by prolonged treatment with the LXR agonist
or by addition of exogenous NAD+, as shown in experiments in
which the cells were acutely stimulated with the sarco-ER Ca2+Figure 4. Synergistic Induction of Cd38 by Inflammatory Signals and L
(A–C) qPCR analysis of Cd38 expression in WT (A–C) or LXR-deficient macropha
LXR agonist T1317 (1 mM, 8 hr in A or 24 hr in B), RXR agonist LG268 (1 mM, 24 hr
(20 ng/mL, 18 hr), IL-10 (10 ng/mL, 18 hr), and TGF-b (2 ng/mL, 18 hr). Data repre
treatment in WT cells. Statistical analysis was performed with a two-way ANOV
comparisons (B), or t test (C).
(D) Intracellular NAD+ levels in WT and CD38-deficient macrophages stimulated
represent mean ± SEM; n = 7 (WT, top), n = 3 (CD38/, top), n = 10 (WT, bottom
(E) Fluorimetric analysis of intracellular ROS production in response to LPS (100 ng
mean ± SD (representative experiment of n = 4, with each experiment using biol
(F) Intracellular NADase activity. Data represent mean ± SEM; n = 5 (WT) and n = 3
two mice). Statistical analysis was performed using a Kruskal-Wallis test. *p < 0.0
same treatment in WT cells.
(G) Luciferase reporter studies in Raw264.7macrophages stably transfected with
enhancer with WT LXRE (Cd38enh WT) or with mutated LXRE (Cd38enh MUT), as
24 hr with vehicle (DMSO), T1317 (1 mM), LPS (100 ng/mL), or a combination of bo
cells transfected with the WT construct (Kruskal-Wallis).
See also Figure S5. *p < 0.05, **p < 0.01.ATPase inhibitor thapsigargin (Figure 5D, bottom). Altogether,
these results suggest that induction of the LXR-CD38 circuit
has no substantial long-term impact on Ca2+ depletion from
the ER in macrophages. In addition, incubation of WT cells
with S. Typhimurium did not lead to significant cytosolic Ca2+
changes in either the presence or absence of an LXR agonist
(Figure 5E), and treatment with 8-bromo-cADPR, an analog of
cADPR that blocks Ca2+ release mediated by ryanodine-recep-
tor-gated stores, did not affect the capability of LXRs to inhibit
macrophage infection (Figure 5F). Based on all of these observa-
tions, we conclude it is the CD38-dependent reduction in NAD+
levels (a consequence of its strong NADase activity) and not the
concomitant generation of potential Ca2+-mobilizing second
messengers that best explains the protective effects on macro-
phage infection induced by the LXR-CD38 axis. Importantly, lack
of functional CD38 expression counteracted the capability of an
LXR agonist to inhibit changes in F-actin redistribution and cell
morphology associated with bacterial infection (Figures 5G–5I).
An Endogenous Pathway Can Activate the LXR-CD38
Axis during Salmonella Infection
Endogenous LXR ligands are generated enzymatically from in-
termediates of the cholesterol biosynthetic pathway or by oxida-
tion of cholesterol by sterol hydroxylases (Spann et al., 2012).
Interestingly, infection of macrophages with S. Typhimurium re-
sulted in reduced expression of several enzymes involved in
cholesterol biosynthesis but a selective prominent increase in
the expression of cholesterol 25-hydroxylase (Ch25h), which
mediates cholesterol oxidation to 25-hydroxycholesterol
(25-HC) (Figure 6A). 25-HC is a relatively weak LXR activator
that is able to induce LXR-mediated transcriptional activity at
high doses (Lala et al., 1997; Janowski et al., 1999). In our
studies, micromolar doses of 25-HC induced the expression of
Cd38, either alone or in synergy with IFN-g (Figure 6B), and
reduced macrophage infection in an LXR- and CD38-dependent
manner (Figures 6C and 6D). 25-HC can modulate inflammatory
responses both positively and negatively in different settings
(Reboldi et al., 2014; Gold et al., 2014). In macrophages infected
with Salmonella, 25-HC exerted dose-dependent repression of
inflammatory genes (Figure 6E). However, these actions were in-
dependent of the LXR-CD38 pathway (Figure 6E), in contrast toXR Activation
ges (A and B) in response to one or more stimuli: S. Typhimurium (MOI 5, 8 hr),
), TNF-a (20 ng/mL, 24 hr), IFN-g (5 ng/mL, 24 hr), LPS (100 ng/mL, 24 hr), IL-4
sent mean ± SEM (n = 3). In (A) and (B), #p < 0.05, ##p < 0.01 versus the same
A Bonferroni (A), Kruskal Wallis followed by Mann-Whitney U test for paired
or not with LPS (100 ng/mL) (top) or TNF-a (20 ng/mL) (bottom) for 24 hr. Data
), and n = 6 (CD38/, bottom) (t test).
/mL) and IFN-g (5 ng/mL) (6 hr) in WT and CD38-deficient cells. Data represent
ogically distinct triplicates).
(LXR/, CD38/) (each experiment performed with cells pooled from at least
5, **p < 0.01 vs control cells from the same genotype; #p < 0.05, ##p < 0.01 vs
LXRa and transiently cotransfectedwith a reporter plasmid containing theCd38
well as a plasmid overexpressing RXRa. Transfected cells were stimulated for
th. Data represent mean ± SEM (n = 4). #p < 0.05 versus the same treatment in
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Figure 5. CD38 Mediates the Protective Effects of LXR Agonists on Macrophage Infection
(A) Effects of the LXR agonist T1317 on the percentage of infected cells (top) and the amount of intracellular bacteria (bottom) in WT and CD38-deficient
macrophages, as assessed by confocal fluorescence microscopy. Data represent mean ± SEM (n = 4; two-way ANOVA Bonferroni).
(legend continued on next page)
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the role in macrophage bacterial infection. Altogether, these ob-
servations suggest that induction of CH25H during the host
innate response against Salmonella may provide local endoge-
nous LXR agonists that limit subsequent macrophage infection
through the LXR-CD38 circuit and, in parallel, activate mecha-
nisms that are independent of LXRs to further keep inflammatory
responses under control.
Pharmacological Treatment with a Synthetic LXR
Agonist Ameliorates the Clinical Signs Associated with
Bacterial Infection In Vivo
Based on the findings described throughout this work, we next
analyzed whether pharmacological treatment with a synthetic
agonist has protective effects on Salmonella infection in vivo.
Mice were administered either vehicle or the LXR agonist
T1317 daily during the course of a lethal infection with S. Thyphi-
muriumandmonitored for the first 5dayspost-infection.Remark-
ably, pharmacological LXR activation resulted in a significant
decrease in body mass loss and in the severity of the clinical
score during the course of infection (Figures 7A and 7B). The
ameliorating effects of the agonistwere abolished in animals defi-
cient in LXRs (Figures 7C and 7D) or CD38 (Figures 7E and 7F). In
LXR/mice, in fact, treatmentwith T1317accelerated the lossof
weight associated to infection. Moreover, in WT mice, but not in
CD38/mice, the agonist decreased the infection index of sple-
nocytes 4 days after the start of infection (Figures 7G and 7H) as
well as the expression of several markers of inflammation in the
liver and spleen (Figure S6), suggesting that pharmacological
activation of LXRs inhibited the capability of orally administered
Salmonella to disseminate and infect distant organs.
To evaluate the specific contribution of bone-marrow-derived
CD38-expressing cells, we analyzed the response to infection in
mice that had been sub-lethally irradiated and transplanted with
eitherWTorCD38-deficientbonemarrow. Interestingly, activation
of the LXR pathway did not reduce the loss of body weight and
other clinical signs associatedwith infection inmice reconstituted
with CD38/ bonemarrow, in contrast to the ameliorating effects
observed in mice transplanted with WT bone marrow (Figures 7I–
7J). In correlation with these observations, treatment with the LXR
agonist significantly inhibited the infection index of splenocytes
(Figure 7K) and the expression of several inflammatory genes in
WT, but not CD38-deficient, bone marrow recipients (Figure S7).
Collectively, these results suggest that CD38 induction in bone-(B) Treatment with IFN-g (5 ng/mL, 24 hr) reduced the infection in WT, but no
represent mean ± SEM (n = 3; Mann-Whitney Wilcoxon).
(C) Repressive effects of T1317 on proinflammatory gene expression in WT and
(n = 5; two-way ANOVA Bonferroni). ##p < 0.01 vs the same treatment in WT ce
(D and E) Videomicroscopic analysis of cytosolic Ca2+ levels inWT (D and E), LXR-
to the analysis, the cells were stimulated with T1317 (1 mM, 24 hr) or vehicle (D
treatment. In (D, bottom), changes in cytosolic Ca2+ levels after inducing Ca2+ mob
(pooled data from three independent experiments; Kruskal Wallis). (E) Representa
in changes in cytosolic Ca2+ levels in cells previously stimulated or not with T1317
mean ± SD (n = 3, each experiment performed in triplicates). Similar results were
(F) Treatment with 8br-cADPR (20 mM, 2 hr) does not impair the capability of T13
macrophage infection. Data represent mean ± SEM (n = 3; ANOVA Bonferroni).
(G–I) Morphological analysis by confocal fluorescence microscopy of CD38-defi
gation ratio (H), and dorsal F-actin accumulation (I). Data represent mean ± SEM
*p < 0.05, **p < 0.01.marrow-derived cells is an important mediator of the ameliorating
actions of the LXR pathway in Salmonella infection.
DISCUSSION
In this study, we have identified a previously unappreciated strat-
egy to inhibit the potential of S. Typhimurium to infect host
macrophages based on pharmacological targeting of the LXR
pathway. A key finding of our work is the mechanism that
accounts for these protective effects, which involves transcrip-
tional upregulation of the multifunctional enzyme CD38. Interest-
ingly, LXR activation did not interfere with phagocytosis of
IgG-opsonized bacteria, suggesting that the protective effects
of LXR agonists do not interfere with bacterial clearance through
Fcg receptors once the adaptive immune system has generated
opsonizing antibodies against the pathogen.
A role for CD38 in the host response against bacteria has
been previously proposed based on increased susceptibility
of CD38-deficient mice to other bacterial strains, in correlation
with defects in immune cell infiltration to sites of infection (Par-
tida-Sa´nchez et al., 2001; Lischke et al., 2013) or with defective
polarization of Th1 immune responses (Viegas et al., 2007). In
this work, we describe a previously unrecognized function of
CD38 in mediating macrophage protection from invasive bacte-
rial infection. The major enzymatic activity of CD38 is consid-
ered to be its NADase activity, as it hydrolyzes 100 molecules
of NAD+ to generate 1 molecule of cADPR (Aksoy et al.,
2006). In the model we propose here, LXR activation reduces
NAD+ levels as a consequence of elevated CD38 expression,
resulting in cytoskeletal changes that interfere with membrane
ruffling and/or other mechanisms subverted by invasive
bacterial strains. Consistent with this model, addition of NAD+
reverted the changes in cell morphology and dorsal F-actin
accumulation in macrophages and rescued the capability of
S. Typhimurium to infect macrophages in the presence of an
LXR agonist. The virulence of invasive Salmonella strains corre-
lates with their capability to induce extensive cell membrane
ruffling and macropinocytosis and enter inside macrophages
via ‘‘spacious phagosomes’’ (Kiama et al., 2006; Alpuche-
Aranda et al., 1995). Among the effectors secreted by S. Typhi-
murium, cell invasion protein A increases the actin polymeriza-
tion rate (Lilic et al., 2003) and Salmonella outer protein E en-
hances the activity of host cell Rho family GTPases involvedt CD38-deficient, macrophages, as assessed by confocal microscopy. Data
CD38-deficient macrophages (qPCR analysis). Data represent mean ± SEM
lls.
deficient (D), and CD38-deficient (D) macrophages loadedwith fura-2 AM. Prior
MSO) with or without exogenous addition of NAD+ (1 mM) for the last 2 hr of
ilization from the ER by thapsigargin (1 mM). In (D), data represent mean ± SEM
tive experiment showing that infection byS. Typhimurium (MOI 20) did not result
. As a control, the response to thapsigargin was also evaluated; data represent
obtained using MOIs 5–10.
17 to inhibit macrophage infection, as assessed by flow cytometry studies of
cient macrophages. Representative images (scale bars, 10 mm) (G), cell elon-
(n = 3; ANOVA Bonferroni).
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Figure 6. Salmonella Infection Induces the Expression of Ch25h in Macrophages
(A) Effects of Salmonella infection on the relative mRNA levels of several enzymes involved in cholesterol and oxysterol biosynthesis. Macrophages were infected
with S. Typhimurium for 30 min, and gene expression was evaluated by qPCR 8 hr post-infection. Mean ± SEM (n = 3; t test). Cyp51, sterol 14a-demethylase;
Dhcr24, 24-dehydrocholesterol reductase; Sqle, squalene epoxidase.
(legend continued on next page)
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Figure 7. Pharmacological Treatment with
a Synthetic LXR Agonist Ameliorates the
Clinical Signs Associated with Salmonella
Infection in a CD38-Dependent Manner
WT (A and B), LXR-deficient (C and D), or CD38-
deficient (E and F) female mice were infected by
oral gavage with S. Typhimurium (107 CFU per
animal). The animals were daily administered by
i.p. injection either vehicle (DMSO in physiologic
saline, black circles) or the LXR ligand T1317
(15 mg/kg animal dissolved in physiologic saline,
magenta squares), starting 24 hr before the
infection; n = 14 (WT), n = 7 (LXR/), and n = 13
(CD38/) mice per group.
(A, C, and E) The weight of each mouse was
measured daily before and after the infection. The
graphics represent estimated marginal means of
mass (±SEM) during the first 4 days post-infection.
Statistical analysis was performed using
repeated-measures two-way ANCOVA after ad-
justing for mass at the time of infection.
(B,D,andF)Developmentofclinical signsduring the
first few days of infection. For each mouse, a score
was calculated based on the presence of clinical
signs (one point for each sign): >15% weight loss,
severe hunched position, ruffled fur, watery eyes, or
slow movement. Dead animals (ǂ) were assigned a
score of 6. Horizontal bars representmean values in
the live population (Mann-Whitney U).
(G and H) WT (G) or CD38-deficient (H) female
mice were orally infected with RFP-expressing
S. Typhimurium (107 CFU per animal) and treated
with vehicle or an LXR agonist as described above.
The infection index in splenocytes after 4 days of
infection was determined by flow cytometry (log
values); n = 5 mice per group (t test).
(I–K) Sub-lethally irradiated WT female mice were
subjected to bone marrow transplantation (3 3
106 bone marrow cells per animal) from either WT
(BMT WT > WT) or CD38-deficient female donors
(BMT CD38/ > WT). Two months after trans-
plantation, the animals were infected with RFP-
expressing S. Typhimurium (107 CFU). Bacterial
infection and administration of LXR agonist or
vehicle was performed as described above. Body
weight (I) and severity score (J) were registered
during 4 days post-infection. The infection index
in splenocytes was evaluated by flow cytometry (K); n = 7–9 mice per group. Estimated marginal means of mass (± SEM) and repeated-measures two-way
ANCOVA after adjusting for mass at the time of infection (I), Mann-Whitney U (J), or t test (K). In (J)–(K), blue horizontal bars indicate mean values.
See also Figures S6 and S7. *p < 0.05, **p < 0.01.in the regulation of the cytoskeleton (Hardt et al., 1998).
Moreover, NAD+ is used as a cofactor to sustain the glycolytic
activity in macrophages and generate ATP for polymerization of(B) Cd38mRNA expression was evaluated by qPCR upon treatment of WT or LXR
absence of IFN-g (5 ng/mL). Mean ± SEM (n = 3; Kruskal-Wallis).
(C) Confocal microscopy studies indicating that incubation with 25-HC (30 mM)
macrophages. Data represent mean ± SEM (n = 3; t test).
(D) Quantification of viable intracellular S. Typhimurium. Macrophages from WT (
(3–30 mM) or vehicle (ethanol) for 18 hr and then infected with S. Typhimurium for 3
of cell lysates on agar. Data represent mean ± SEM (n = 6; ANOVA Bonferroni).
(E) 25-HC modulates inflammatory gene expression independently of LXR and C
with S. Typhimurium. Inflammatory gene expression was determined by qPCR 6
*p < 0.05, **p < 0.01.F-actin filaments and may also modulate actin dynamics
through several other mechanisms (Yin et al., 2012; Venter
et al., 2014).-deficient macrophages with the indicated doses of 25-HC in the presence or
reduced infection by S. Typhimurium in WT, but not LXR- or CD38-deficient,
left), LXR-deficient (middle), or CD38-deficient (right) were treated with 25-HC
0min. Quantification of intracellular bacterial CFUs after plating serial dilutions
D38. Macrophages were treated with 25-HC (0.3–30 mM) 18 hr before infection
hr post-infection. Data represent mean ± SEM (n = 4; ANOVA Bonferroni).
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We have identified a functional LXRE that conferred LXR/RXR
agonist responsiveness to a Cd38 enhancer-directed luciferase
construct. Interestingly, CD38 expression can be also induced
byothermembersof thenuclear receptor family, including retinoic
acid receptor alpha (Drach et al., 1994) and peroxisome prolifera-
tor-activated receptor gamma (Song et al., 2012). Although we
cannot discard possible cooperation between other RXR hetero-
dimeric partners andLXRs, the induction ofmacrophageCD38by
LXR/RXRagonists and the protectivemechanismuncoveredhere
depends on functional LXR expression, suggesting that these ef-
fects are mediated directly by LXR-RXR heterodimers.
Another major insight from this report is that cooperative ac-
tions between LXRs and inflammatory signals translate into syn-
ergistic induction of CD38 expression and its NADase activity.
Our reporter studies suggest that these effects occur through
combined actions at the transcriptional level, which contrasts
with general mutually repressive activities between LXRs and
LPS or IFN-g (Castrillo et al., 2003; Ghisletti et al., 2007; Pasc-
ual-Garcı´a et al., 2013). Our results support the notion that
such cooperative regulation of macrophage CD38-dependent
NADase activity represents a protective mechanism to control
excessive internalization of live bacterial cells. This mechanism
may be induced endogenously to some extent through induction
of CH25H during infection and subsequent production of the
oxysterol 25-HC. Micromolar doses of 25-HC resulted in CD38
upregulation and protection from macrophage infection in an
LXR- and CD38-dependent manner, raising the possibility that,
within infected tissues, intracellular or locally secreted 25-HC
levels that reach the threshold to activate the LXR pathway, in
combination with inflammatory mediators, contribute to limit
intracellular macrophage infection.
Importantly, pharmacological treatment with a high-affinity
LXR agonist ameliorated the levels of infection in the spleen
and the clinical signs of disease after oral administration of S. Ty-
phimurium in a CD38-dependent manner. Once they have in-
fected intestinal epithelial cells, Salmonella cells continue to
disseminate to other organs and their intracellular life within
macrophages is essential for dissemination. We therefore hy-
pothesize that pharmacological activation of the LXR-CD38 cir-
cuit, most probably enhanced by mediators in the inflammatory
milieu, protects uninfected macrophages from posterior infec-
tion, therefore restraining the capability of Salmonella cells to
disseminate throughout the body. Moreover, the LXR agonist
also exerts anti-inflammatory actions that contribute to amelio-
ration of the severity score of disease. Interestingly, despite
the fact that LXR agonists repress macrophage inflammatory
gene expression independently of CD38 in vitro, the induction
of a number of inflammatory mediators in both the spleen and
the liver of Salmonella-infected animals was downregulated by
the LXR agonist in WT, but not CD38-deficient, mice. We inter-
pret that two mechanisms affecting the extent of inflammation
may be operating simultaneously in vivo: on one hand, LXR
may repress the inflammatory response independently of
CD38, and, on the other hand, the LXR-CD38 axis protects mac-
rophages from infection, thus reducing bacterial dissemination
to other organs and indirectly contributing to downregulated
inflammation. Beyond these considerations, we cannot discard
the contribution of other mechanisms regulated by LXRs, such1252 Cell Reports 18, 1241–1255, January 31, 2017as induction of SPa/AIM, a protein that protects macrophages
from bacterial-induced cell death (Joseph et al., 2004; Valledor
et al., 2004) and regulates autophagy during mycobacterial
infection (Sanjurjo et al., 2015). Importantly, our bone marrow
transplantation studies provide evidence that the expression of
CD38 specifically in bone-marrow-derived cells is important for
the LXR-mediated effects described here, including the reduc-
tion in the levels of splenocyte infection, the extent of inflamma-
tion, and other clinical signs associated with Salmonella
infection. Our studies, however, do not exclude that CD38
expression in bone-marrow-derived cells other than macro-
phages (e.g., neutrophils) contributes to the observed effects
of the LXR agonist in vivo. Indeed, the concerted activities of
CD38 seem to favor the extracellular permanence of invasive
bacterial strains, as suggested here, and the chemotaxis of neu-
trophils to sites of infection (Partida-Sa´nchez et al., 2001), which
may, in parallel, promote extracellular bacterial killing and limit
macrophage-mediated dissemination. In consideration of
evolving antimicrobial resistance in certain parts of the world,
this work strengthens the relevance of LXR agonists or drugs
that potentiate CD38 NADase activity as potential therapeutic
strategies in host-directed therapy against infections that use
the macrophage as a niche for replication.
EXPERIMENTAL PROCEDURES
See Supplemental Experimental Procedures for more information.
Animal Strains
All the protocols requiring animal manipulation have been approved by the
ethical committee from Parc Cientı´fic de Barcelona, University of Barcelona,
Mayo Clinic and Institut Pasteur in Montevideo.
Cell Cultures
Bone-marrow-derived macrophages were obtained from bone marrow pre-
cursors differentiated for 6–7 days in DMEM (PAA Laboratories) supplemented
with 20% heat-inactivated fetal bovine serum (FBS) (PAA) and 30% L-cell
conditioned medium. Both female and male mice were used indistinctively
for generation of primary macrophages. Raw264.7 macrophages and COS-7
(ATCC) cells were grown in DMEM 10% heat-inactivated FBS.
In Vitro Infection
Macrophages were plated in cell culture plates containing DMEM 10% FBS
and infected with S. Typhimurium or E. coli for 30 or 60 min at different
MOIs (5–20). Non-internalized bacterial cells were eliminated by three washes
with PBS. In some experiments, macrophages were then incubated for 1 hr in
complete medium containing 100 mg/mL gentamicin (Sigma-Aldrich) to kill
extracellular bacteria and then switched to complete medium with a lower
dose of gentamicin (10 mg/mL) and processed at different times post-infection.
In some experiments, S. Typhimurium was opsonized with anti-Salmonella
LPS IgG (Santa Cruz Biotechnology) for 2 hr at 4C.
Determination of Macrophage Infection by Flow Cytometry
Infected cells were fixed in PBS 4% paraformaldehyde, and cells containing
fluorescent bacteria (RFP+) were counted using a FacsAria I SORP sorter
(Becton Dickinson). In each experiment, non-infected cells were used as inter-
nal controls of macrophage auto-fluorescence, and cells infected at 4C were
used to distinguish attached versus internalized bacteria. For more detailed
information, see Supplemental Experimental Procedures.
Confocal Fluorescence Microscopy
Infected macrophages were washed with PBS and fixed with 4% parafor-
maldehyde for 10 min. After two additional washes with PBS, the cells were
incubated with wheat germ agglutinin (WGA)-Alexa 488 (2.5 mg/mL,
10 min) or Bodipy-fluorescein isothiocyanate (FITC) (4 mg/mL, 30 min)
(Life Technologies) to stain cell membranes. In some experiments, F-actin
filaments were stained with phalloidin-Alexa 633 (Life Technologies)
(10 mg/mL) for 30 min at 37C. Cell nuclei were stained with DAPI
(1 mg/mL) for 5 min, whereas intracellular bacteria were detected by RFP
emission. The cells were mounted in Vectashield (Vector Laboratories).
Confocal images and z stack sections were acquired using Leica TCS
SP2 and SP5 confocal microscopes (Leica Microsystems) and processed
with ImageJ software. Five random fields per coverslip were recorded
and, in each experiment, at least triplicate coverslips were generated for
each condition.
In Vivo Infection
In experiments evaluating the clinical signs of infection, adult (3–5 months
old) WT, LXR-deficient, or CD38-deficient female mice were pretreated
with 10% sodium bicarbonate for 10 min and then infected by oral gavage
with S. Typhimurium (107 CFU in 200 mL saline solution per animal). To eval-
uate the effects of LXR activation on morbidity, the animals were daily
administered by intraperitoneal (i.p.) injection either vehicle (DMSO) or the
LXR ligand T1317 (15 mg/kg animal) dissolved in physiologic saline, starting
24 hr prior to infection. Each animal was daily monitored for weight changes
and other parameters associated with infection-induced morbidity, and a
clinical scoring system was defined according to the development of any
of the following clinical signs (one point for each sign): >15% weight loss, se-
vere hunched position, ruffled fur, watery eyes, or slow movement. In some
experiments, the mice were sacrificed at day 4 post-infection, and the infec-
tion index in the spleen was determined. In these assays, the spleens were
disaggregated through a 100-mm cell strainer, and the erythrocytes were
lysed using 1X Pharm Lyse lysing solution (BD Biosciences). The splenocytes
were fixed in PBS 5% paraformaldehyde, and the percentage of infected
cells (containing RFP+ bacteria) was analyzed by flow cytometry. An infec-
tion index was calculated for each animal by using the following formula:
infection index = (percentage of RFP+ splenocytes) 3 (mean fluorescence in-
tensity in the RFP+ population). Spleen samples from non-infected mice
were used as negative controls.
Irradiation and Bone Marrow Transfer
Eight-week-old C57BL/6 females were sub-lethally irradiated with two
sessions of 4.5 Gy separated by 4 hr. The animals were then injected with
3 3 106 bone marrow cells from either WT or CD38-deficient female donors.
These procedures were carried out at the animal facility of Parc de Recerca
Biome`dica Barcelona (PRBB). Two months after the bone marrow transfer,
the mice were treated with an LXR agonist or vehicle and infected with S. Ty-
phimurium as indicated above. Blood, spleen, and bone marrow specimens
from non-infected mice were used to analyze the efficiency of replacement
of the hematopoietic system. In these assays, surface CD38 expression was
analyzed through flow cytometry. See Supplemental Experimental Procedures
for more information.
RNA Extraction and Quantitative Real-Time PCR Determination
Total RNA was extracted using TRIzol Reagent (Life Technologies) as recom-
mended by the manufacturer. More information on cDNA synthesis and quan-
titative real-time PCR (real-time qPCR) can be found in Supplemental Experi-
mental Procedures. Primers used for measuring specific gene expression are
described in Table S1.
Protein Extraction and Western Blot Analysis
Cells were washed in cold PBS and lysed on ice in RIPA buffer (25mMTris-HCl
[pH 7.6], 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, and 0.1% SDS)
supplemented with protease inhibitors. The samples were processed as
described in Supplemental Experimental Procedures.
NAD Cycling Activity
To determine intracellular NAD+ levels, 3 3 106 macrophages were lysed in
10% trichloroacetic acid (TCA) (Sigma-Aldrich) by sonication. Sonicated sam-
ples were centrifuged at 12,000 rpm for 2 min. The supernatants werecollected, and the pellets were resuspended in 0.2 N NaOH for protein deter-
mination. TCA extraction was performed on the supernatants by adding 2 vol
1,1,2-trichloro-1,2,2-trifluroethane and 3 vol trioctylamine. After phase
separation, the top aqueous layer containing NAD+ was recovered, and
its pH was adjusted to 8.0. In a 96-well plate, 100 mL of each sample diluted
in water was mixed with 100 mL of a cycling reagent solution (100 mM
NaH2PO4 [pH 8], 0.76% ethanol, 4 mM riboflavin 5
0-monophosphate,
27.2 U/mL alcohol dehydrogenase, 0.24 U/mL diaphorase, and 8 mM resa-
zurin) and incubated for 20 min in the dark. The samples were monitored
every min for 60 min in a fluorescence plate reader (excitation wavelength =
544 nm; emission wavelength = 590 nm). A standard curve with known con-
centrations of NAD+ was used to determine the amount of NAD+ in the pro-
cessed samples. The data were normalized by the amount of protein in each
sample.
NADase Activity
NADase activity was measured using a fluorescence-based assay. In each
sample, 53 106 macrophages were lysed by sonication in Sucrose-Tris buffer
(0.25 M sucrose, 40 mM Tris [pH 7.4], and protease inhibitors). The samples
were excited at 300 nm and the fluorescence was measured at 410 nm. After
the baseline was recorded, 80 mM of 1,N6-etheno-adenine dinucleotide was
added to start the reaction. The emission of fluorescence was followed at
37C every min for 1 hr in a Gemini XPS fluorescence microplate reader
(Molecular Devices). NADase activity was calculated as the slope of the linear
portion of the fluorescence-time curve, corrected by the amount of protein in
each sample. The final results are expressed as NADase activity (df/dt) per
milligram protein. For each experimental condition, duplicate samples were
processed.
Statistical Analysis
Statistical analyses were performed with SPSS software (IBM). For data with
normal distribution, an ANOVA Bonferroni test or a Student’s t test was used
to determine statistical differences between multiple or paired comparisons,
respectively. Instead, a Kruskal-Wallis Dunn’s test or a Mann-Whitney U Wil-
coxon test was used for data without normal distribution. In experiments eval-
uating changes of body weight along the course of infection, a repeated-mea-
sures two-way ANCOVA was used, adjusting for weight at day 0 of infection.
Differences were considered significant when p < 0.05.
To make different experiments comparable in Figures 1A and 2C, the data
were normalized using the following procedure. The intensity of each experi-
ment (ie) was calculated by determining the mean value of infection between
the vehicle-treated control and the T1317-treated WT cells. The intensities of
separate experiments were normalized by the mean intensity value of all the
experiments (im) and, for each experiment, the resulting normalization factor
(im/ie) was multiplied with the percentage of infected cells of all the samples
in that experiment. Similar calculations were applied to Figures 3G, 3L, 4D,
and 4G.
The accession number for the microarray datasets reanalyzed in this work is
MIAMExpress: E-MEXP-3871 (Pascual-Garcı´a et al., 2013).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and one table and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2017.01.007.
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